Atopic Dermatitis Archives - Page 2 of 5 - MPR

Atopic Dermatitis

Tradipitant Misses Primary End Point in Atopic Dermatitis Trial

Vanda Pharmaceuticals announced data from the phase 3 EPIONE study of tradipitant for the treatment of pruritus in atopic dermatitis. The 8-week, multicenter, double-blind, placebo-controlled study evaluated the efficacy of tradipitant, a neurokinin-1 receptor antagonist, in 341 adult patients with atopic dermatitis who presented with severe pruritus. Patients were randomized 1:1 to receive either tradipitant…